SMTI compared with RNAC: revenue, margins and what each company keeps, and the suppliers and customers both name

SMTISanara MedTech Inc.

Mkt capRevenueRevenue

RNACCartesian Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SMTISanara MedTech Inc.

RNACCartesian Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SMTISanara MedTech Inc.

32.38▲+0.97%

Mkt cap$301.6MRevenue$28MQ2 FY26Revenue$103MFY25

RNACCartesian Therapeutics, Inc.

6.53▲+3.00%

Regular sessionNov 3 '26

Mkt cap$191.8MRevenue$78,000Q1 FY26Revenue$3MFY25

Compare

Regular sessionNov 3 '26

SMTISanara MedTech Inc.

RNACCartesian Therapeutics, Inc.

32.38▲+0.97%

Price

6.53▲+3.00%

$301.6M

Mkt cap

$191.8M

Q2 FY26$28M

Revenue

$78,000Q1 FY26

FY25$103M

Revenue

$3MFY25

SMTI32.38▲+0.97%vsRNAC6.53▲+3.00%Regular sessionNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SMTI: latest quarter is a loss; flow not drawable. RNAC: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SMTI 0

None

Shared 0

No disclosed counterparties: SMTI.

Only RNAC 8

BIIBBiogen MA, Inc., or Biogensupplier

—National Institutes of Healthunlistedsupplier

—Genovis AB (publ.)unlistedsupplier

—NCIunlistedsupplier

4 more · RNAC chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

SMTI, solidRNAC, dashed